Particle uptake and translocation occur at specific sites in the gastr
ointestinal tract. Several drugs are also absorbed from solution only
through narrow 'windows' in the small intestine. In these circumstance
s, optimum therapeutic benefit would be obtained if the active agent w
as targeted to the appropriate site in the gastrointestinal tract. Tar
geting relies on exploiting a unique feature of the intended site and
protecting the active agent until it reaches that site, This minirevie
w highlights the problems in achieving site specificity in the gastroi
ntestinal tract and examines possible solutions to the problem for 2 r
egions, the stomach and the colon.